Actively Recruiting
Evaluation of Short-Chain Fatty Acids to Reduce Inflammation and Support Cognitive Function After Experimental Inflammatory Challenge in Healthy Adults
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2026-07-20
56
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether short-chain fatty acids SCFAs, substances produced by gut bacteria during fiber fermentation, can reduce inflammation and support brain function after an inflammatory challenge in healthy adults aged 18 to 45. The study explores SCFAs effects on the immune response, mental performance, and related sickness symptoms following a controlled inflammation triggered by a low dose of lipopolysaccharide LPS, a bacterial substance that activates the immune system and causes mild flu-like symptoms. Participants are randomly assigned to receive either SCFA colon-delivery capsules or matching placebo capsules on the morning of a test day, taken with a standardized low-fiber breakfast. One hour later, all participants receive a single intravenous dose of purified LPS to induce inflammation. The study monitors participants for at least six hours after LPS injection, collecting blood, saliva, and stool samples to measure inflammatory markers, SCFA levels, stress hormones, and gut bacteria. Cognitive tasks assessing working memory, inhibition, and cognitive flexibility are performed before and after the LPS challenge and again 24 hours later. The study involves three visits a screening visit lasting about one hour, a laboratory test day of approximately eight hours with continuous monitoring, and a follow-up visit about 24 hours after the LPS challenge. Researchers measure markers such as serum interleukin-6, C-reactive protein, cortisol, and ACTH, as well as sickness symptoms and executive function performance. Participants follow a low-fiber diet for three days before the test day and avoid caffeine, alcohol, and strenuous exercise to standardize results. The trial aims to clarify SCFAs role in reducing inflammation and protecting brain function during acute immune activation.
CONDITIONS
Brief Title
Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function
Research Team
F
Franco Ruiz, M.D.
D
Dina Satriawan, M.D., Mnsci(Adv)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here